1492-1493 / 2063
Overview
•
Introduction
•
Target driven lethality
•
EGFR inhibitors
•
Synthetic lethality
•
DNA-repair inhibitors
•
Contextual lethality
•
VEGF inhibitors
•
Vascular disrupting agents
•
Immune activation
•
Take home messages
2
Chapter 21
M Baumann & V Grégoire